Takeda, a biopharmaceutical innovation player, has launched its Innovation Capability Center (ICC) in Bengaluru. The center plans to hire over 750 people across various roles in CY25.

The Indian innovation centre arm will collaborate closely with Takeda’s other ICCs, including those in Slovakia and Mexico. The Bengaluru center is expected to develop solutions that enhance patient care by leveraging advanced technologies such as AI, data analytics, and digital health platforms.

These solutions will include personalised tools to help patients manage complex conditions, multi-language digital platforms to improve care accessibility, and data-driven insights to inform healthcare strategies, according to Tilak Banerjee, Head of Takeda ICC India.

Banerjee stated, “Globally, these innovations accelerate the development of transformative treatments, improve patient engagement, and streamline healthcare operations, ensuring consistent, high-quality outcomes for patients.”

Discussing partnerships, Banerjee highlighted that Takeda has collaborated with local startups, universities, and research institutions. “We also work with organisations like the Biotechnology Industry Research Assistance Council (BIRAC) to mentor and support healthcare entrepreneurs,” he added.